Jeff brings more than 25 years of experience to The Deerborne Group as a proven leader with significant commercial and operations experience in the global in-vitro diagnostics and CLIA laboratory services market.
Jeff started out his career working for Fortune 500 companies such as Abbott, Bayer, and Quest Diagnostics. In 2010, Jeff was a member of the senior executive leadership team at Clarient (Nasdaq: CLRT) when the business was acquired by GE Healthcare for $587 million. Jeff has since worked for venture-backed startup and mid-stage molecular diagnostic CLIA laboratories where he has held senior executive, commercial, operational, and GM roles.
Jeff received his undergraduate degree from UCLA and is a former U.S. Navy SEAL.